Does CLOMIPRAMINE Cause Product use in unapproved indication? 180 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 180 reports of Product use in unapproved indication have been filed in association with CLOMIPRAMINE (Clomipramine Hydrochloride). This represents 4.7% of all adverse event reports for CLOMIPRAMINE.
180
Reports of Product use in unapproved indication with CLOMIPRAMINE
4.7%
of all CLOMIPRAMINE reports
3
Deaths
130
Hospitalizations
How Dangerous Is Product use in unapproved indication From CLOMIPRAMINE?
Of the 180 reports, 3 (1.7%) resulted in death, 130 (72.2%) required hospitalization, and 16 (8.9%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOMIPRAMINE. However, 180 reports have been filed with the FAERS database.
What Other Side Effects Does CLOMIPRAMINE Cause?
Drug ineffective (561)
Toxicity to various agents (427)
Suicide attempt (375)
Off label use (271)
Coma (262)
Intentional overdose (237)
Weight increased (214)
Akathisia (204)
Obsessive-compulsive disorder (187)
Therapeutic product effect incomplete (184)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which CLOMIPRAMINE Alternatives Have Lower Product use in unapproved indication Risk?
CLOMIPRAMINE vs CLONAZEPAM
CLOMIPRAMINE vs CLONIDINE
CLOMIPRAMINE vs CLOPIDOGREL
CLOMIPRAMINE vs CLOPIDOGREL BESILATE
CLOMIPRAMINE vs CLOPIDOGREL BISULFATE